Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Tuesday. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Up 7.6 %

Shares of MLSS stock opened at $1.27 on Tuesday. The company has a market capitalization of $98.92 million, a price-to-earnings ratio of -18.14 and a beta of 1.10. Milestone Scientific has a 12-month low of $0.54 and a 12-month high of $1.30. The firm has a fifty day moving average of $0.91 and a 200-day moving average of $0.91.

Hedge Funds Weigh In On Milestone Scientific

Several hedge funds and other institutional investors have recently made changes to their positions in MLSS. Y Intercept Hong Kong Ltd bought a new stake in Milestone Scientific in the third quarter valued at approximately $48,000. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the third quarter worth approximately $91,000. Carnegie Investment Counsel boosted its holdings in shares of Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after acquiring an additional 27,412 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.